Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


Articles published in Curr Opin Oncol

Retrieve available abstracts of 7 articles:
HTML format
Text format



Single Articles


    January 2018
  1. KOELBLINGER P, Thuerigen O, Dummer R
    Development of encorafenib for BRAF-mutated advanced melanoma.
    Curr Opin Oncol. 2018 Jan 18. doi: 10.1097/CCO.0000000000000426.
    PubMed     Text format     Abstract available


    December 2017
  2. DIMITRIOU F, Braun RP, Mangana J
    Update on adjuvant melanoma therapy.
    Curr Opin Oncol. 2017 Dec 18. doi: 10.1097/CCO.0000000000000432.
    PubMed     Text format     Abstract available


  3. CHENG PF
    Medical bioinformatics in melanoma.
    Curr Opin Oncol. 2017 Dec 8. doi: 10.1097/CCO.0000000000000428.
    PubMed     Text format     Abstract available


  4. CHUA V, Aplin AE
    Novel therapeutic strategies and targets in advanced uveal melanoma.
    Curr Opin Oncol. 2017 Dec 4. doi: 10.1097/CCO.0000000000000425.
    PubMed     Text format     Abstract available


    September 2017
  5. SILVA IP, Long GV
    Systemic therapy in advanced melanoma: integrating targeted therapy and immunotherapy into clinical practice.
    Curr Opin Oncol. 2017 Sep 12. doi: 10.1097/CCO.0000000000000405.
    PubMed     Text format     Abstract available


  6. WARNER SG, O'Leary MP, Fong Y
    Therapeutic oncolytic viruses: clinical advances and future directions.
    Curr Opin Oncol. 2017;29:359-365.
    PubMed     Text format     Abstract available


    December 2016
  7. DUMMER R, Ramelyte E, Levesque M, Goldinger SM, et al
    Critical aspects to achieve a high-quality melanoma clinic.
    Curr Opin Oncol. 2016 Dec 23. doi: 10.1097/CCO.0000000000000357.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: